Network Analysis of Urinary Molecular Signature Complements Clinical Data to Predict Postoperative Acute Kidney Injury

Study acronym: NavigateAKI
StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed
    • Final enrollment: 94 participants (planned 240)
    • Primary completion date changed from estimate of Jun 2030 to Dec 1, 2025
    • Eligibility criteria expanded, about 10 words
  2. Notable Primary completion date: Jun 2025 to Jun 2030
    • Study completion date: Dec 2028 to Dec 2030
    v23
  3. Minor Study completion date: Dec 2025 to Dec 2028v22
  4. Minor Re-verified, no change to tracked fieldsv21
  5. Notable Primary completion date: Jun 2023 to Jun 2025
    • Collaborators shortened, about 3 words
    v20
Show 18 earlier versionsHide 18 earlier versions
  1. Minor Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Jun 2023 to Dec 2025
    • Site details revised
    v19
  2. Minor Primary and study completion dates: Dec 2022 to Jun 2023
    • Site contact updated
    v18
  3. Notable Primary and study completion dates: Dec 2021 to Dec 2022v17
  4. Notable Primary and study completion dates: Dec 2020 to Dec 2021v16
  5. Minor Collaborator revisedv15
  6. Minor Site contact updatedv14
  7. Notable Primary and study completion dates: Dec 2019 to Dec 2020v13
  8. Minor Re-verified, no change to tracked fieldsv12
  9. Notable Trial status: Active, Not Recruiting to Recruiting
    • Primary and study completion dates: Jul 2019 to Dec 2019
    • Site details revised
    v11
  10. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v10
  11. Minor Enrollment target: 200 to 240
    • Collaborators expanded, about 4 words
    v9
  12. Minor Re-verified, no change to tracked fieldsv8
  13. Notable Primary and study completion dates: Jul 2017 to Jul 2019v7 Show 4 more changesShow less
    • Interventions: pathogenesis of perioperative acute kidney injury (Procedure) to pathogenesis of perioperative acute kidney injury (Procedure), urine collection (Diagnostic Test)
    • Eligibility criteria expanded, about 68 words
    • Study description expanded, about 23 words
    • Study arms: 1 to 2
  14. Minor Site contact updatedv6
  15. Minor Re-verified, no change to tracked fieldsv5
  16. Notable Trial status: Active, Not Recruiting to Recruiting
    • Start date: Mar 2015 to Jul 2015
    • Primary and study completion dates: Apr 2017 to Jul 2017
    • Site details revised
    v4
  17. Notable Primary completion date: Apr 2015 to Apr 2017
    • Start date: Apr 2014 to Mar 2015
    • Study completion date: Apr 2016 to Apr 2017
    v3
  18. Minor Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Site contact updated
    v2
  1. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The risk for postoperative acute kidney injury (pAKI), as for any other postoperative complications (PC), comes from a number of interactions between a patient's health before surgery, strength to tolerate surgery and influences on the operating room environment. At this time doctors do not have good tools to predict which patients may be at risk of having this complication. The purpose of this research study is to develop a urine test that can be used to predict the risk for having problems with kidney function after major surgery.
Trial Details
NCT Number NCT02114138
Lead Sponsor University of Florida
Conditions
(from sponsor)
Acute Kidney Injury
Related terms Acute Kidney Injury, Renal Insufficiency, Chronic
Enrollment 94 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov